Prazincox, δισκία για σκύλους και γάτες
Prazincox, δισκία για σκύλους και γάτες
Authorised
- Fenbendazole
- Praziquantel
Product identification
Medicine name:
Prazincox, δισκία για σκύλους και γάτες
Active substance:
- Fenbendazole
- Praziquantel
Target species:
-
Dog
-
Cat
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Fenbendazole500.00/milligram(s)1.00Tablet
-
Praziquantel50.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP52AA51
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Greece
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete application (stand-alone)
Marketing authorisation holder:
- Tafarm Ltd.
Marketing authorisation date:
Manufacturing sites for batch release:
- aniMedica GmbH
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 38994/30-03-2020/K-0195301
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Greek (PDF)
Published on: 8/11/2022